Home » Topics » BioWorld Science

BioWorld Science
RSS

Pyxis Oncology enters worldwide agreement with Pfizer to develop and commercialize novel ADCs

March 22, 2021

New phase Ib/II trial evaluates CM-24 in advanced cancer

March 19, 2021

Phase II study of AMY-101 for periodontal inflammation and gingivitis meets endpoints

March 19, 2021

PGT-121 is effective without effector functions

March 19, 2021

FDA approves Arcalyst for recurrent pericarditis

March 19, 2021

Incyte reports phase III results with ruxolitinib for COVID-19-associated ARDS

March 19, 2021

Sarepta Therapeutics presents results for SRP-9001 gene therapy in nonhuman primates

March 19, 2021

Idera reports ORR endpoint data from phase III trial of tilsotolimod for advanced melanoma

March 19, 2021

Phase II interim analysis data presented for apitegromab in patients with SMA

March 19, 2021

China's NMPA approves emergency use of recombinant protein subunit vaccine against COVID-19

March 19, 2021

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...